Cite
HARVARD Citation
Gnekow, A. et al. (2017). A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report. European journal of cancer. pp. 206-225. [Online].